Olme 40 Tablet

About Olme 40 Tablet

Made by Albion Laboratories Ltd., Olme 40 is a tablet whose active ingredient is Olmesartan Medoxomil. Lowering high blood pressure helps to reduce the risk of serious health problems such as heart attack and stroke.

There are 29 brands of Olmesartan Medoxomil listed in Bangladesh. The lowest listed price is Belsar 10 mg Tablet at ৳ 6.00 per unit.

What is Olme 40 Tablet?

The tablet Olme 40 contains Olmesartan Medoxomil and is made by Albion Laboratories Ltd. By blocking this effect, the medicine helps blood vessels relax. It is used in the treatment of hypertension and may be taken alone or together with other blood pressure medicines. The dose and course are set by your doctor depending on your condition.

Uses of Olme 40

Lowering high blood pressure helps to reduce the risk of serious health problems such as heart attack and stroke. It can be prescribed on its own or alongside other medicines that lower blood pressure. High blood pressure often has no obvious symptoms, so the medicine is taken as part of a plan set by your doctor. Do not change or stop the medicine without medical advice.

How to use Olme 40

If a dose is missed, ask the doctor or pharmacist for guidance on what to do. Swallow the tablet with water. Olme 40 is taken by mouth. Take Olme 40 40 mg tablet by mouth as directed by your doctor. The dose and course are decided by the doctor and may be adjusted based on your response. Do not change the dose yourself.

Side effects of Olme 40

If any side effect bothers you or does not go away, speak to your doctor or pharmacist. Common side effects include back pain, bronchitis, increased creatine phosphokinase, diarrhoea, headache, blood in urine, high blood sugar, high triglycerides, flu-like symptoms, sore throat, runny nose, and sinusitis. Rarely, chest pain, swelling of the limbs, and arthritis have been reported.

Safety and precautions

Before taking Olme 40 40 mg, tell your doctor if you are allergic to olmesartan or any of the ingredients. Breastfeeding mothers should ask the doctor, as it is not known whether the medicine passes into human milk. Always tell your doctor about other medicines and health conditions before starting.

Frequently asked questions

Why is Olme 40 prescribed?

Lowering high blood pressure helps to reduce the risk of serious health problems such as heart attack and stroke. It can be prescribed on its own or alongside other medicines that lower blood pressure.

How is Olme 40 used?

If a dose is missed, ask the doctor or pharmacist for guidance on what to do. Swallow the tablet with water.

What should I watch for while using Olme 40?

If any side effect bothers you or does not go away, speak to your doctor or pharmacist. Common side effects include back pain, bronchitis, increased creatine phosphokinase, diarrhoea, headache, blood in urine, high blood sugar, high triglycerides, flu-like symptoms, sore throat, runny nose, and sinusitis.

Who should be careful with Olme 40?

Before taking Olme 40 40 mg, tell your doctor if you are allergic to olmesartan or any of the ingredients. Breastfeeding mothers should ask the doctor, as it is not known whether the medicine passes into human milk.

Indications

Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Pharmacology

Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).

Dosage & Administration

Dosage must be individualized. The usual recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan may be increased to 40 mg. Doses above 40 mg do not appear to have a greater effect. Twice-daily dosing offers no advantage over the same total dose given once daily.

No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40 ml/min) or with moderate to marked hepatic dysfunction. For patients with possible depletion of intravascular volume (e.g. patients treated with diuretics, particularly those with impaired renal function), Olmesartan should be initiated under close medical supervision and consideration should be given to use of a lower starting dose. Olmesartan may be administered with or without food.

Interaction

With medicine: No significant drug interactions were reported in which Olmesartan was co-administered.
With food & others: Food does not affect the bioavailability of Olmesartan.

Contraindications

Olmesartan is contraindicated in patients who are hypersensitive to any component of this product.

Side Effects

Common: The most common side effects include Back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Rare: Chest pain, peripheral edema, arthritis.

Pregnancy & Lactation

Pregnancy: When pregnancy is detected, discontinue this product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.

Nursing Mothers: It is not known whether Olmesartan is excreted in human milk, but Olmesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan medoxomil.

Overdose Effects

Symptoms: There is no experience of overdose with Olmesartan. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.

Treatment: If intake is recent, gastric lavage or induction of emesis may be considered. Clinically significant hypotension due to an overdose of Olmesartan requires the active support of the cardiovascular system, including close monitoring of heart and lung function, the elevation of the extremities, and attention to circulating fluid volume and urine output.

Storage Conditions

Store in cool & dry place below 30ºC, protect from light & moisture. Keep out of the reach of children.

Alternative brands of Olmesartan Medoxomil

Other brands with the same generic name, cheapest first.

See all 29 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.